Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary

被引:21
作者
Allegra, Carmen J.
Rumble, Bryan
Schilsky, Richard L.
机构
[1] Univ Florida, Gainesville, FL USA
[2] Amer Soc Clin Oncol, Alexandria, VA USA
关键词
D O I
10.1200/JOP.2015.007898
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:180 / +
页数:3
相关论文
共 2 条
[1]
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 [J].
Allegra, Carmen J. ;
Rumble, R. Bryan ;
Hamilton, Stanley R. ;
Mangu, Pamela B. ;
Roach, Nancy ;
Hantel, Alexander ;
Schilsky, Richard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02) :179-+
[2]
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy [J].
Allegra, Carmen J. ;
Jessup, J. Milburn ;
Somerfield, Mark R. ;
Hamilton, Stanley R. ;
Hammond, Elizabeth H. ;
Hayes, Daniel F. ;
McAllister, Pamela K. ;
Morton, Roscoe F. ;
Schilsky, Richard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) :2091-2096